tirzepatide fda Lilly's Zepbound (aka tirzepatide) Lands Approval for Weight Loss Tirzepatide Wins FDA Approval for

Higher serum concentrations of betaine rather than choline is associated with better profiles of DXA-derived body fat and fat distribution in Chinese adults

Presented for research literature review only Wu L et al

doi: 10.3233/JPD-181329

The dual-action mechanism typically produces more consistent appetite control than single-pathway medications at this stage

Retatrutide is currently undergoing large-scale Phase 3 clinical trials (the TRIUMPH program)

Ingredients: Lipotropic (MIC: Methionine, Inositol, Choline) B12 (100mcg/mL methylcobalamin) REQUIREMENT: Upon approval of the physician, medications are shipped out